Top 10 Considerations in Supplements for Hair

1THE DATA BENCHMARKS: A REVIEW OF THE EVIDENCE FOR STANDARDIZED NUTRACEUTICALS
Multitargeted, standardized nutraceuticals are supported by prospective, randomized trial data.

Marine Protein Complexes

Studies show that oral marine–derived complexes improve hair growth kinetics. In a 3-month trial (n=60), a marine complex supplement significantly increased terminal hair counts and reduced shedding compared with placebo.1 Similarly, a 6-month trial (n=15) demonstrated substantial increases in terminal hair counts vs placebo-treated participants.2

Standardized Botanical Nutraceuticals

Multitargeted formulations addressing cortisol, oxidative stress, and androgen signaling provide a comprehensive whole-body approach to hair thinning. A 6-month study (n=40) using standardized botanicals revealed significant increases in both terminal and vellus hair counts.³ Another 6-month trial in men (n=85) showed significant global improvements in hair growth and quality (P < 0.01), with no sexual side effects.4

A recent network meta-analysis of 19 trials confirmed that dietary supplements, including plant extracts and probiotics, consistently improved hair density compared with placebo.5

2LONGEVITY AND AGE-RELATED CHANGES:
THE ROLE OF AUTOPHAGY AND SENESCENCE
Age-dependent hair thinning manifests as either androgenetic or senescent alopecia. Both involve follicular miniaturization, but they are driven by different pathways: androgenetic alopecia is driven by hormonal sensitivity and androgen-driven regression, whereas senescent alopecia is associated with stem cell exhaustion, oxidative stress, and mitochondrial dysfunction.6

As the scalp ages, autophagic capacity declines and follicular atrophy increases. Spermidine, a potent autophagy activator, restores autophagic flux.7 In a 90-day trial (n=100), oral spermidine significantly increased anagen phase hairs and cellular proliferation markers while reducing cell death vs placebo.8 Supplements targeting autophagy and senescent pathways in aging populations may help maintain anagen duration and dampen senescence-associated microinflammation.

3MENOPAUSE AND HORMONAL SHIFTS:
THE ROLE OF DHT BLOCKERS
Menopause accelerates female pattern hair loss as declining estrogen removes follicular protection, allowing dihydrotestosterone (DHT) to drive miniaturization.⁹ Botanical DHT blockers, such as standardized saw palmetto, provide a well-tolerated option by inhibiting 5-alpha-reductase activity.¹⁰

The only clinical trial that has evaluated a hair growth nutraceutical formulated specifically for menopausal women included standardized saw palmetto, maca, astaxanthin, and other phytonutrients targeting root causes of hair thinning. In this 6-month randomized, double-blind, placebo-controlled trial (n=70), the nutraceutical significantly increased terminal and total hair counts and reduced shedding by 32.4%.¹¹ Combining botanical DHT inhibitors with adaptogens offers an evidence-based strategy to mitigate menopausal hair thinning.

4BIOTIN: REALITY VS HYPE
Biotin is a key metabolic cofactor for protein synthesis. Historically considered rare, biotin deficiency has been reported to affect up to 38% of women presenting to a hair loss clinic. This is potentially linked to gut dysbiosis, among other known causes of biotin deficiency (eg, pregnancy, antibiotics, medications, alcohol use disorder).¹²

Megadose biotin (5,000 μg to 10,000 μg) causes immunoassay interference, producing falsely elevated or suppressed thyroid and cardiac markers.¹³ Patients should hold high-dose supplements for 48 to 72 hours before testing.

Regarding anecdotal concerns about acnegenesis, evidence remains limited. Interestingly, adjunctive biotin has been studied to prevent isotretinoin-associated hair thinning. In one study, patients on a combination of isotretinoin and biotin demonstrated improved anagen/telogen ratios and skin hydration at 4 months when compared with isotretinoin alone.¹⁴

For management of hair thinning associated with biotin deficiency, low to moderate (30–2500 μg) doses adequately treat deficiency while minimizing laboratory interference risks.^15,16

5POSTPARTUM HAIR LOSS
Postpartum telogen effluvium affects nearly half of new mothers, caused by the abrupt withdrawal of pregnancy-related estrogen and progesterone, which triggers synchronized hair shedding.¹⁷ This physiologic process is often compounded by lactation-associated nutrient depletion (specifically iron, zinc, and Vitamin D)¹⁸ and postpartum stress. Because standard antiandrogenic botanicals are contraindicated while breastfeeding, nutraceutical formulations focused on bioavailable micronutrient repletion and lactation-safe botanicals are preferred. A 6-month randomized, double-blind, placebo-controlled trial (n=70) demonstrated that a standardized nutraceutical, containing shatavari, marine collagen, and DHA, significantly improved hair density (P < .001) and reduced shedding (P < .01) without safety concerns for mothers or infants.¹⁹ Clinicians should screen for nutrient deficiencies (eg, ferritin <30 ng/mL) while offering breastfeeding-safe formulations to accelerate recovery to baseline density in postpartum women experiencing hair thinning.

6VITAMIN D AND FERRITIN IN HAIR LOSS
Evaluating ferritin and vitamin D levels is essential for managing nonscarring alopecia, yet standard reference ranges often overlook thresholds required for follicular health. Serum ferritin levels of 30 ng/mL are necessary to prevent telogen shedding.²⁰ To optimize hair density and anagen retention, clinicians should target at least 40 ng/m.²¹

Similarly, vitamin D signaling via the vitamin D receptor is required to initiate anagen; deficiency is strongly associated with diffuse shedding and alopecia areata.²² In patients with hair thinning, clinicians should target vitamin D levels of 40 to 60 ng/mL.

7PEDIATRICS AND NUTRITIONAL GAPS
Pediatric hair loss makes up 7% of dermatology visits and most commonly includes alopecia areata, infections, and telogen effluvium.²³ Pediatric follicles are uniquely vulnerable to nutritional depletion, as rapid growth prioritizes essential organ development over skin appendages. Common drivers of diffuse shedding include iron, zinc, and vitamin D deficiency.²⁴ Dermatologists should consider targeted workups (including ferritin, complete blood count, zinc, vitamin D, and thyroid-stimulating hormone) and, when indicated, use physiologic, pediatric-safe supplement formulations. Adult nutraceutical formulations should be avoided due to potential endocrine disruption risks; instead, safe, age-appropriate micronutrient correction should be pursued to resolve underlying deficiencies.

8NUTRACEUTICALS VS ESTABLISHED PHARMACOTHERAPIES
As nutraceuticals gain popularity, comparison with US Food and Drug Administration–approved pharmacotherapies is of interest. However, direct cross-trial comparisons are limited by variations in baseline severity and hair classifications. Nevertheless, data demonstrate efficacy across key hair health parameters.

Terminal/Nonvellus Hair Count (Increase at 6 Months): In studies, oral minoxidil 5 mg daily yielded a 10.2% to 23.6% increase,^25,26 extended-release minoxidil 4.5 mg daily produced a 16.5% increase,²⁷ and topical minoxidil 5% achieved a 12.3% increase.²⁸ A multitargeted nutraceutical in women achieved a 10.4% increase,3 and a marine complex reached a 7.4% increase.²⁹

Hair Diameter: A multitargeted nutraceutical produced a 6% to 9% increase in fiber diameter at 6 months,³⁰ achieving results similar to topical minoxidil 2% (7% at 9 months)³¹ and oral minoxidil 5 mg (10% at 12 weeks).²⁵

Hair Growth Rate: A multitargeted nutraceutical increased linear growth rate by 0.04 to 0.06 mm/d at 6 months,³² which is similar to that reported in a small study of topical minoxidil 3% (0.04 mm/d over 16 weeks).³³

9THE GUT–HAIR AXIS:
PROBIOTICS AND THE GUT MICROBIOME
Emerging research highlights the gut–hair axis, wherein intestinal dysbiosis promotes systemic microinflammation, compromises epithelial barrier function, and disrupts hair cycle kinetics. Modulating the gut microbiome using oral prebiotics, postbiotics, and probiotics—such as Lactobacillus and Bifidobacterium strains—presents an innovative, root-cause strategy to upregulate short-chain fatty acids, enhance nutrient bioavailability, and modulate cutaneous immunity.³⁴

In a 16-week randomized, double-blind, placebo-controlled trial (n=115), supplementation with a Lactiplantibacillus strain mixture significantly reduced the number of telogen hairs (P < 0.05) and prevented follicular miniaturization in androgenetic alopecia.³⁵ A meta-analysis of 8 randomized clinical trials and preclinical studies examining probiotics in hair growth found a nonsignificant improvement in hair count and a significant improvement in hair thickness.³⁶ Modulating the gut microbiome via targeted probiotics, prebiotics, and postbiotics may offer a promising, root-cause approach to hair health.

10REVERSING VS PREVENTING:
SUPPLEMENTS FOR GRAY HAIR
Canities (hair graying) is a progressive process driven by melanocyte stem cell depletion and oxidative stress. As follicles age, hydrogen peroxide accumulates, inactivating tyrosinase and halting melanin synthesis. Acquired canities are often reversible through micronutrient repletion (eg, vitamin B12, copper, iron), whereas senescent greying, where the melanocyte stem cell reservoir is exhausted, is irreversible. Oral nutraceuticals may serve a preventative role by preserving melanocyte viability, quenching reactive oxygen species, and providing cofactors like L-tyrosine and copper to support enzymatic synthesis.³⁷

A randomized, double-blind, placebo-controlled study (n=173) demonstrated that a combination of an oral supplement and topical serum significantly reduced gray hair density after 24 weeks compared with placebo.³⁸ Studies are limited, but supplements may help delay progression and correct underlying deficiencies associated with acquired graying. More research is needed to understand the role of oral supplements in reversing established, senescent gray hair.

CONCLUSION

Clinical trial data and mechanistic research on oral hair supplementation continue to grow. By understanding ingredient mechanisms and population-specific safety, dermatologists can effectively integrate evidence-based nutraceuticals into the management of hair thinning.

Disclosure: Dr. Woolery-Lloyd serves as the Chief Medical Advisor for Nutrafol.